Myriad Genetics (MYGN)
NASDAQ:MYGN
Holding MYGN?
Track your performance easily

Myriad Genetics (MYGN) Income Statement

345 Followers

Myriad Genetics Income Statement

Last quarter (Q2 2024), Myriad Genetics's total revenue was $211.50M, an increase of 15.26% from the same quarter last year. In Q2, Myriad Genetics's net income was $-35.90M. See Myriad Genetics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Jun 20Jun 19
Total Revenue
$ 802.20M$ 753.20M$ 678.40M$ 690.60M$ 638.60M$ 851.10M
Cost of Revenue
$ 248.20M$ 236.20M$ 202.00M$ -185.70M$ 186.10M$ 201.00M
Gross Profit
$ 554.00M$ 517.00M$ 476.40M$ 493.00M$ 452.50M$ 650.10M
Operating Expense
$ 663.00M$ 661.60M$ 600.10M$ 619.70M$ 584.50M$ 641.40M
Operating Income
$ -155.90M$ -257.40M$ -140.60M$ -126.70M$ -132.00M$ 8.70M
Net Non Operating Interest Income Expense
$ -100.00K$ -400.00K$ -600.00K$ -5.90M$ -7.80M$ -8.80M
Other Income Expense
$ -200.00K$ 4.40M$ -600.00K$ -139.30M$ -83.50M$ 100.00K
Pretax Income
$ -156.60M$ -262.20M$ -140.60M$ -57.10M$ -223.30M$ 0.00
Tax Provision
$ -1.40M$ 1.10M$ -28.60M$ -29.90M$ -23.70M$ -4.40M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -154.40M$ -263.30M$ -112.00M$ -27.20M$ -199.50M$ 4.60M
Basic EPS
$ -1.81$ -3.18$ -1.39$ -0.35$ -2.69$ 0.06
Diluted EPS
$ -1.81$ -3.18$ -1.39$ -0.35$ -2.69$ 0.06
Basic Average Shares
$ 348.70M$ 82.80M$ 80.60M$ 78.00M$ 74.30M$ 73.50M
Diluted Average Shares
$ 348.70M$ 82.80M$ 80.60M$ 78.00M$ 74.30M$ 76.00M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
----$ -0.08$ 1.67
Rent Expense Supplemental
------
Total Expenses
$ 457.20M$ 897.80M$ 802.10M$ 434.00M$ 770.60M$ 842.40M
Net Income From Continuing And Discontinued Operation
$ -155.20M$ -263.30M$ -112.00M$ -27.20M$ -199.50M$ 4.60M
Normalized Income
$ -68.89M-$ -152.30M-$ -110.38M$ 5.70M
Interest Expense
----$ 10.80M$ 12.00M
EBIT
$ -122.80M$ -259.30M$ -137.40M$ -54.90M$ -212.50M$ 12.00M
EBITDA
$ -70.70M$ -197.40M$ -73.00M$ 20.70M$ -140.50M$ 85.00M
Currency in USD

Myriad Genetics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis